Short Interest in Gain Therapeutics, Inc. (NASDAQ:GANX) Drops By 17.9%
Gain Therapeutics, Inc. (NASDAQ:GANX – Get Rating) was the target of a large decline in short interest during the month of March. As of March 15th, there was short interest totalling 30,800 shares, a decline of 17.9% from the February 28th total of 37,500 shares. Approximately 0.4% of the shares of the company are sold […]